BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 34915638)

  • 61. Survival and Trends in Annualized Hazard Function by Age at Diagnosis Among Chinese Breast Cancer Patients Aged ≤40 Years: Case Analysis Study.
    Wang J; Luo T; Xiang ZZ; He MM; Zeng YY; Yang T; Wei XY; Yu S; Dai ZL; Xu NY; Tan CF; Liu L
    JMIR Public Health Surveill; 2023 Jul; 9():e47110. PubMed ID: 37463020
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The prognostic contribution of clinical breast cancer subtype, age, and race among patients with breast cancer brain metastases.
    Anders CK; Deal AM; Miller CR; Khorram C; Meng H; Burrows E; Livasy C; Fritchie K; Ewend MG; Perou CM; Carey LA
    Cancer; 2011 Apr; 117(8):1602-11. PubMed ID: 21472708
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Impact of the 21-gene recurrence score assay in clinical treatment and prognosis analysis for patients with hormone receptor positive early-stage breast cancer].
    Zhang YN; Zhou YD; Mao F; Guan JH; Lin Y; Wang XJ; Shen SJ; Wang CJ; Yao R; Sun Q
    Zhonghua Zhong Liu Za Zhi; 2018 Feb; 40(2):110-114. PubMed ID: 29502370
    [No Abstract]   [Full Text] [Related]  

  • 64. Comparison of breast cancer recurrence and outcome patterns between patients treated from 1986 to 1992 and from 2004 to 2008.
    Cossetti RJ; Tyldesley SK; Speers CH; Zheng Y; Gelmon KA
    J Clin Oncol; 2015 Jan; 33(1):65-73. PubMed ID: 25422485
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Prognostic impact of pregnancy after breast cancer according to estrogen receptor status: a multicenter retrospective study.
    Azim HA; Kroman N; Paesmans M; Gelber S; Rotmensz N; Ameye L; De Mattos-Arruda L; Pistilli B; Pinto A; Jensen MB; Cordoba O; de Azambuja E; Goldhirsch A; Piccart MJ; Peccatori FA
    J Clin Oncol; 2013 Jan; 31(1):73-9. PubMed ID: 23169515
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Prognostic analysis of benign, borderline and malignant phyllodes tumors of the breast].
    Wang H; Wang X; Wang C
    Zhonghua Zhong Liu Za Zhi; 2015 Dec; 37(12):923-7. PubMed ID: 26887622
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The insulin-like growth factor family and breast cancer prognosis: A prospective cohort study among postmenopausal women in Denmark.
    Kalledsøe L; Dragsted LO; Hansen L; Kyrø C; Grønbæk H; Tjønneland A; Olsen A
    Growth Horm IGF Res; 2019 Feb; 44():33-42. PubMed ID: 30622040
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Left laterality is an independent prognostic factor for metastasis in N3 stage breast cancer.
    Karatas F; Sahin S; Erdem GU; Ates O; Babacan T; Akin S; Sever AR; Ozisik Y; Altundag K
    J BUON; 2016; 21(4):851-858. PubMed ID: 27685905
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Thyrotropin suppression therapy using levothyroxine does not negatively affect breast cancer prognosis.
    He X; Zhong M; Zhang Q; Aierken N; Cui L; Xing Z; Lei K
    Cancer Treat Res Commun; 2022; 31():100525. PubMed ID: 35114502
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Association with pregnancy increases the risk of local recurrence but does not impact overall survival in breast cancer: A case-control study of 87 cases.
    Genin AS; De Rycke Y; Stevens D; Donnadieu A; Langer A; Rouzier R; Lerebours F
    Breast; 2016 Dec; 30():222-227. PubMed ID: 26456897
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Validation of CTS5 on a Retrospective Cohort of Real-Life Pre- and Postmenopausal Patients Diagnosed With Estrogen Receptor-Positive Breast Cancers: Is It Prognostic?
    Villasco A; Agnelli F; D'Alonzo M; Accomasso F; Sismondi P; Biglia N
    Clin Breast Cancer; 2021 Feb; 21(1):e53-e62. PubMed ID: 32703705
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Combined-modality treatment for isolated recurrences of breast carcinoma: update on 30 years of experience at the University of Texas M.D. Anderson Cancer Center and assessment of prognostic factors.
    Hanrahan EO; Broglio KR; Buzdar AU; Theriault RL; Valero V; Cristofanilli M; Yin G; Kau SW; Hortobagyi GN; Rivera E
    Cancer; 2005 Sep; 104(6):1158-71. PubMed ID: 16047352
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Clinical features and prognosis of 25 cases of breast carcinosarcoma].
    Yang YF; Liu J; Fang ZY; Gu L
    Zhonghua Zhong Liu Za Zhi; 2012 Aug; 34(8):620-3. PubMed ID: 23158999
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Predictive analysis of distant metastasis after primary treatment of papillary thyroid cancer in patients under 18 years old].
    Wang X; Zhang Y; Zhao M; Mao XC; Tan Z; Shang JB; Wang XL; Wang KJ
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 Jul; 55(7):664-670. PubMed ID: 32668875
    [No Abstract]   [Full Text] [Related]  

  • 75.
    Groheux D; Martineau A; Teixeira L; Espié M; de Cremoux P; Bertheau P; Merlet P; Lemarignier C
    Breast Cancer Res; 2017 Jan; 19(1):3. PubMed ID: 28057031
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Endocrine sensitivity is decisive for patient outcome in small node-negative breast cancers (BC) (pT1a,b) - results from the Munich Cancer Registry.
    Kolben T; Harbeck N; Wuerstlein R; Schubert-Fritschle G; Bauerfeind I; Schrodi S; Engel J
    Breast; 2015 Feb; 24(1):24-31. PubMed ID: 25543874
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Age at initial diagnosis and prognosis of breast cancer: a nationwide multicenter retrospective study in China.
    Yang H; Ouyang QC; Yan M; Wang XJ; Hu XC; Jiang ZF; Huang T; Tong ZS; Wang SS; Yin YM; Li H; Yang RX; Yang HW; Teng YE; Sun T; Cai L; Li HY; Ouyang XN; He JJ; Liu XL; Yang SE; Fan JH; Wang JY; Qiao YL; Xu BH
    Ann Transl Med; 2022 Aug; 10(15):813. PubMed ID: 36034985
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Clinicopathological features and prognostic factors of 22 cases of primary squamous cell carcinoma of the breast].
    Yanqi Z; Lina Z; Lin G
    Zhonghua Zhong Liu Za Zhi; 2015 Apr; 37(4):293-6. PubMed ID: 26462895
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Evaluation of the pathologic and prognostic correlates of estrogen receptors in primary breast cancer.
    Skinner JR; Wanebo HJ; Betsill WL; Wilhelm MC; Drake CR; Macleod RM
    Ann Surg; 1982 Dec; 196(6):636-41. PubMed ID: 7149814
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Is conservative surgery a good option for patients with "triple negative" breast cancer?
    Martinez-Ramos D; Escrig-Sos J; Torrella-Ramos A; Alcalde-Sanchez M; Salvador-Sanchis JL
    Breast; 2012 Jun; 21(3):401-5. PubMed ID: 22579462
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.